82 results
Page 3 of 5
S-3ASR
6x04fgi
19 Apr 21
Automatic shelf registration
4:11pm
PRE 14A
qhvj3 ous7
14 Apr 21
Preliminary proxy
4:00pm
10-K
EX-10.20
qpshoxekjro0l57cb
1 Mar 21
Annual report
12:00am
10-K
EX-10.30
6gao lgfr
1 Mar 21
Annual report
12:00am
10-K
EX-10.29
inmky8k8gon
1 Mar 21
Annual report
12:00am
10-K
7lwy1 yiosuhdmje
1 Mar 21
Annual report
12:00am
10-K
EX-10.32
0pnrn6gy0zb4q n5urp
1 Mar 21
Annual report
12:00am
10-K
EX-10.33
wum5s3
1 Mar 21
Annual report
12:00am
10-K
EX-10.21
isg8k
1 Mar 21
Annual report
12:00am
10-K
EX-10.22
pyag79w78lbf7s
1 Mar 21
Annual report
12:00am
8-K
EX-99.1
x1zvmri er
6 Jan 21
Zai Lab granted exclusive rights to develop and commercialize efgartigimod in Greater China
4:08pm
424B5
hnus15s8snqsgy 2f
23 Sep 20
Prospectus supplement for primary offering
8:06am
6-K
EX-1.1
1opd 32app6m3j3f746k
21 Sep 20
Current report (foreign)
4:15pm
424B5
x7hl 3zzidyogz
16 Sep 20
Prospectus supplement for primary offering
7:24am
6-K
EX-99.1
xzra1k2a
11 Sep 20
Current report (foreign)
8:16am
6-K
EX-99.1
hv9rsjf
11 Sep 20
Zai Lab Limited Supplemental and Updated Disclosures
8:09am